Antivert and Phoslo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Antivert (meclizine hydrochloride) and Phoslo (calcium acetate). Common drug interactions include pain among females.

The phase IV clinical study analyzes what interactions people have when they take Antivert and Phoslo. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.

What is Phoslo?

Phoslo has active ingredients of calcium acetate. eHealthMe is studying from 4,291 Phoslo users. Check the latest studies of Phoslo.



On Jul, 20, 2026

27 people who take Antivert and Phoslo together, and have interactions are studied.

Antivert and Phoslo drug interactions.

What are the common drug interactions of Antivert and Phoslo, by gender? *:

female:

  1. Pain
  2. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  3. Skin tightness
  4. Pain in extremity
  5. Pruritus (severe itching of the skin)
  6. Swelling
  7. Erythema (redness of the skin)
  8. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  9. General physical health deterioration (weak health status)
  10. Injury

male:

n/a

What are the common drug interactions of Antivert and Phoslo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  2. Upper respiratory tract infection
  3. Urinary retention (the inability to completely or partially empty the bladder)
  4. Vomiting
  5. Weight increased
  6. Abdominal pain lower
  7. Abdominal pain upper
  8. Atelectasis (partial or complete collapse of the lung)
  9. Atherosclerosis (disorder of the arteries)
  10. Autonomic neuropathy (malfunction of the autonomic nervous system (ans))

50-59:

  1. Activities of daily living impaired
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Chest pain
  5. Dry skin
  6. Emotional distress
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Joint contracture (a permanent shortening of a muscle or joint)
  9. Joint stiffness
  10. Mobility decreased (ability to move is reduced)

60+:

  1. Cardiac arrest
  2. Haemorrhage (bleeding)
  3. Anaemia (lack of blood)
  4. Breathing-related sleep disorder
  5. Cheyne-stokes respiration (abnormal pattern of breathing combination of slow and faster)
  6. Dyspnoea exertional (breathlessness or shortness of breath)
  7. Dyspnoea paroxysmal nocturnal (respiratory distress that awakens patients from sleep)
  8. Epistaxis (bleed from the nose)
  9. Haematochezia (passage of stools containing blood)
  10. Hepatomegaly (abnormal enlargement of the liver)

What are the existing conditions these people have? *

  1. High Blood Pressure: 5 people, 18.52%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 14.81%
  3. Nuclear Magnetic Resonance Imaging Brain: 4 people, 14.81%
  4. Diabetes: 4 people, 14.81%
  5. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 14.81%
  6. Anaemia (lack of blood): 4 people, 14.81%
  7. Pain: 2 people, 7.41%
  8. Myositis (inflammation of the muscles): 2 people, 7.41%
  9. Muscle Aches (muscle pain): 2 people, 7.41%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Antivert and Phoslo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Antivert and Phoslo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Phoslo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Antivert and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phoslo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meclizine hydrochloride and calcium acetate (the active ingredients of Antivert and Phoslo, respectively), and Antivert and Phoslo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: